drugset / Trial / NCT00006468

Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

NCT00006468 ↗

RandomizedOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which regimen of combination chemotherapy is more effective for metastatic colorectal cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two combination chemotherapy regimens in treating patients who have metastatic colorectal cancer.

Timeline

Start
2000-01
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule — Intravenous
Subject Oxaliplatin Small molecule — Intravenous
Subject fluorouracil Small molecule — Intravenous

Indications